APA

Luangmonkong T., Suriguga S., Bigaeva E., Boersema M., Oosterhuis D., de Jong K. P., Schuppan D., Mutsaers H. A. M. & Olinga P. (20180430). Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. : British journal of pharmacology.

Chicago

Luangmonkong Theerut, Suriguga Su, Bigaeva Emilia, Boersema Miriam, Oosterhuis Dorenda, de Jong Koert P, Schuppan Detlef, Mutsaers Henricus A M and Olinga Peter. 20180430. Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. : British journal of pharmacology.

Harvard

Luangmonkong T., Suriguga S., Bigaeva E., Boersema M., Oosterhuis D., de Jong K. P., Schuppan D., Mutsaers H. A. M. and Olinga P. (20180430). Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. : British journal of pharmacology.

MLA

Luangmonkong Theerut, Suriguga Su, Bigaeva Emilia, Boersema Miriam, Oosterhuis Dorenda, de Jong Koert P, Schuppan Detlef, Mutsaers Henricus A M and Olinga Peter. Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. : British journal of pharmacology. 20180430.